Work smarter, not harder
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree very nice buy.
ETLS up 100% with less than 4mil in vol.
ETLS up 100% on less than 4mil in vol.
ETLS .0013 x .0014 watch it
Nice vol comming in, maybe a good play for the rest of the week.
Keep a watch on ETLS, vol comming in
ETLS heating up
Yeah I see that, seems like a good sign
RBID seems like it may go back to the .01 range
GTHA (.045) Enters Into Letter of Intent With Mezey Howarth Racing Stables
Market Wire "US Press Releases "
WHEAT RIDGE, CO -- (MARKETWIRE) -- 06/18/07 -- GeneThera, Inc. (OTCBB: GTHA) announced today it has agreed with Mezey Howarth Racing Stables to provide testing for Equine Infectious Anemia (EIA). Mezey Howarth Racing Stables has agreed to guarantee GeneThera 1,000 tests for EIA at $20 per test.
GeneThera has further agreed to develop a vaccine for EIA. The letter of intent is for a $1,000,000 contract plus a percent of profits from the commercialization of the vaccine.
"EIA affects a small population of horses," said Paul Howarth, "but if one of our horses gets infected our entire stable can be affected."
"The development of the vaccine is the first of many planned agreements with GeneThera," said J. Wade Mezey. "We are expecting the testing to begin soon and the vaccine development to begin in October."
"This letter of intent and the subsequent contract is exciting for GeneThera," said Dr. Tony Milici. "It allows GeneThera to expand its current model to Equines thereby expanding the potential for GeneThera."
The vaccine development is slated to begin in October.
ABOUT GENETHERA, INC.
GeneThera, Inc. is a biotechnology company that develops molecular testing and DNA vaccines for animal diseases that may cause diseases in humans. The core of its operation is the ongoing development of molecular diagnostic assays using Real Time Fluorogenic Polymerase Chain Reaction (F-PCR) technologies to detect the presence of infectious disease from the blood of animals, particularly, live animals.
ABOUT MEZEY HOWARTH RACING STABLES, INC.:
Mezey Howarth Racing Stables, Inc. acquires, owns, manages, trains, races and ultimately syndicates thoroughbred racing prospects. The Company's strategy since inception has been to acquire and maintain a stable of race horses adequate to compete in the middle to upper echelons of the Thoroughbred horse racing industry. The primary focus of the company is on the acquisition of claimers, although horses of racing age may be acquired from time to time depending upon the then existing circumstances.
Application of the Safe Harbor of the Private Securities Litigation Reform Act of 1995:
This press release contains, and GeneThera may from time to time make, written or oral "forward-looking statements" within the meaning of the U.S. federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and other factors, many of which are outside GeneThera's control, that could cause actual results to differ materially from such statements. In particular, statements using words such as "may," "should," "estimate," "expect," "anticipate," "intend," "believe," "predict," "potential," or words of similar import generally involve forward-looking statements.
Contact:
GeneThera, Inc.
Dr. Tony Milici
CEO
(303) 463-6371
The Mezey Howarth Group
J. Wade Mezey/Paul Howarth
Genethera@mezeyhowarth.com
(949) 429-4007
GTHA slow start, but slow and steady wins the race, we should close green agian. The spead should tighten from .045 x .049 to .048 x .049 then we will be in good shape.
Oh yeah keep your radar on this one.
GTHA .0465 X .047
SLWF moving agian
GTHA bid ut looking good
GTHA .048 UP
SLWF nice 6k buy.
GTHA bid ut
SLWF volume comming in
GTHA more news out
OH yeah ETLS, is on my radar.
keep a radar on GTHA they have a lot of potential.
This company has a lot going for it. They are changing their whole governance policy, by electing 4 board memebers at a share holders meeting on July 26th. We should get a pr about that. They are also going to open up a monthly phone conferences for shareholder that will start in August. This goes to show that the company cares about it's share holders. They want to know our opinion towards the them. Today they announced that they are going to develope a vaccine for Equine infectious anemia virus, and provide testing for Mezey Howarth Racing Stables. Mezey Howarth Racing Stable announced that they may fill a 15c211 and become a public trading company. Who know this may be the start of a new beginning.
GTHA nice green close
GTHA nice green close.
GTHA getting pretty good hits at .045 may ut before EOD.
Look like GTHA will close at HOD. Better than close below it.
GTHA rose nicely, lets see what the last 15min of the trading day has for it
GTHA warming up for power hour. I expect to see more buys like that.
GTHA .045 up, it's green
.045 up nice it's green
.044 up Wow!
GTHA .043 x .044
GTHA big buy comming in. May close green
GTHA just ut may close green
GTHA buys are comming in
At these levels we should see some EOD action.
ETLS now .0015 x .0016. Seem like a good buying oportunity. This thig ut on less a million in volume. with a little buying pressure it sould break. .0024 and then there is no turning back. LEts see what the EOD has in store.
ETLS expecting EOD ralley, during power hour
That makes sense, that is why the pps keep going up because we are expecting something around the 27th.